Drug
Clevudine Tenofovir Placebo
Clevudine Tenofovir Placebo: highest development phase Phase 3, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| CLEVUDINE + TENOFOVIR PLACEBO NCT00823342 | Phase 3 | HBe Negative Chronic Hepatitis B |
Latest
No recent events.
Follow Clevudine Tenofovir Placebo on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.